Success with Danna

What fantastic news!

🚨 Breaking News: President Biden has signed the National Plan to End Parkinson’s Act into law! This is the first-ever federal legislation dedicated to ending Parkinson’s disease.

This monumental bill can make an impact by:
💵 Dramatically increasing federal research funding
🔬 Developing more effective pathways for treatments and cures
🩺 Improving early diagnosis
🥼 Sparking new and improved models for patient care
⚖️ Addressing health disparities in diagnosis, treatment, and clinical trial participation

We would like to thank all the Parkinson’s advocates, volunteers and people who wrote to their senators and representatives to make this bill become law.

“The Parkinson’s Foundation is excited for what comes next,” said John Lehr, Parkinson’s Foundation President and CEO. “We look forward to having input in designing exactly how this bill will mobilize meaningful change for the one million Americans living with this disease.”

Learn more: Parkinson.org/blog/awareness/national-plan

Very exciting to see that now a simple skin test can help with an earlier and more accurate diagnoses of Parkinson's. Parkinson's Foundation Houston Area Parkinson Society

Parkinson’s warning in skin biopsy — Harvard Gazette Medical office procedure identifies key biomarker that may lead to more reliable diagnosis of neurodegenerative disorders.

Every 6 minutes. Parkinson's Foundation Houston Area Parkinson Society

You can contact the Parkinson's Foundation Helpline at 1-800-4PD-Info Parkinson's Foundation Houston Area Parkinson Society

1.2 million people in the U.S. will be living with Parkinson's by 2030. Parkinson's Foundation Houston Area Parkinson Society

How young is too young? Parkinson's Foundation Houston Area Parkinson Society

10 Early Signs of Parkinson's Parkinson's Foundation Houston Area Parkinson Society

Know the ABCs of PD Parkinson's Foundation Houston Area Parkinson Society Society

Parkinson's Awareness Month This April is Parkinson’s Awareness Month and we’re partnering with Mitsubishi Tanabe Pharma America to help people understand the complexity of Parkinson’s disease (PD).